Bailard Inc. Has $1.97 Million Stock Holdings in Cardinal Health, Inc. $CAH

Bailard Inc. increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 106.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,560 shares of the company’s stock after acquiring an additional 6,476 shares during the quarter. Bailard Inc.’s holdings in Cardinal Health were worth $1,971,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the stock. SJS Investment Consulting Inc. lifted its position in shares of Cardinal Health by 1,363.6% in the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the period. Jones Financial Companies Lllp increased its position in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC raised its stake in Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares during the last quarter. American Capital Advisory LLC lifted its holdings in Cardinal Health by 5,200.0% in the third quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the period. Finally, Vermillion & White Wealth Management Group LLC boosted its position in Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Down 0.9%

CAH stock opened at $208.39 on Thursday. The firm has a market capitalization of $49.51 billion, a PE ratio of 31.43, a P/E/G ratio of 1.42 and a beta of 0.65. Cardinal Health, Inc. has a twelve month low of $120.72 and a twelve month high of $215.48. The stock’s 50 day moving average is $205.71 and its 200-day moving average is $175.68.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same period in the prior year, the firm posted $1.88 EPS. Cardinal Health’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were issued a dividend of $0.5107 per share. The ex-dividend date was Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s payout ratio is 30.77%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Evercore ISI lifted their price objective on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. Deutsche Bank Aktiengesellschaft raised their target price on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Mizuho set a $222.00 price target on Cardinal Health in a report on Monday, January 12th. Finally, Leerink Partners set a $240.00 price objective on shares of Cardinal Health in a research report on Tuesday, January 13th. Fourteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $216.33.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.